RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
GUIDANCE FINAL
Draft guideline on the requirements for demonstrating therapeutic equivalence for nasal products
Published: 10/8/2026Detected: 10/8/2026

Summary preview

Defines a stepwise, evidence-based framework for demonstrating therapeutic equivalence for nasal products with the same active moiety(ies), prioritizing in vitro data and using pharmacokinetics as a surrogate for local…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
respiratory
pediatrics
immunology
#therapeutic equivalence
#nasal products
#bioequivalence
#pharmacokinetics
#systemic safety

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system12/7/2026
  • Unified application programming interface (API) platform event12/2/2026
  • Committee for Advanced Therapies (CAT): 2-4 December 202612/2/2026
  • Committee for Medicinal Products for Veterinary Use (CVMP): 1-3 December 202612/1/2026
  • Committee for Orphan Medicinal Products (COMP): 1-3 December 202612/1/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.